CLMTCalumet, Inc

Company: Calumet, Inc. (NASDAQ: CLMT) Form: 8-K (Items 2.02, 9.01) Filed with the SEC: November 6, 2026 Current Price: $40.75 | Today's Change: -6.00%

---

What Happened

Calumet, Inc. filed an 8-K with the SEC on November 6, 2026, disclosing its Q2 FY2026 financial results under Item 2.02 (Results of Operations and Financial Condition). Revenue for the quarter came in at $2.02 billion, while the company recorded a net loss of $309.9 million, translating to a basic and diluted loss per share of -$3.58. The operating loss for the quarter was $149.7 million, underscoring that the losses were not merely below-the-line items — the core business was itself operating in the red during the period.

---

Why It Matters

The scale of the net loss is the most immediate concern for investors. A $309.9 million net loss on $2.02 billion in revenue represents a net margin of approximately -15%, a significant shortfall that will raise questions about near-term cash consumption and balance sheet durability. The operating loss of $149.7 million is particularly notable because it indicates that revenue, despite topping $2 billion, was insufficient to cover operating costs during the quarter. For a company whose shares have already declined 6% on the day of this report, the market is clearly treating these results as a material negative. This follows StockWatch's existing initiating coverage on CLMT — investors will want to assess how these results bear on the fundamental thesis laid out in that September 2026 report.

---

Analysis

A few key dynamics are worth watching:

• Operating vs. net loss gap: The operating loss was $149.7 million, while the net loss was $309.9 million — a gap of roughly $160 million that suggests substantial below-the-line charges, potentially including interest expense, derivative losses, or other non-operating items. The filing does not break these out in the structured data provided, so investors should examine the full financial statements attached under Item 9.01 for clarification.

• Revenue scale provides context but not comfort: At $2.02 billion in quarterly revenue, Calumet is not a small or low-volume operation. The fact that such a revenue base still results in a nine-figure operating loss points to either a cost structure problem, a margin compression event (potentially driven by commodity spread dynamics), or one-time charges embedded in the quarter. Identifying which of these is structural versus transient will be critical.

• Stock reaction is significant: A -6% single-day move on earnings day reflects genuine investor concern. The key question going forward is whether this quarter represents an anomalous trough or a reflection of a deteriorating business environment for the company's core specialty products and fuels segments.

• What to watch next: Management's commentary (if provided in the full 8-K exhibit) on the drivers of the operating loss, any updates to full-year guidance, and near-term liquidity or debt metrics will be the most important signals for investors monitoring the stock from here.

---

Disclaimer

This report is an informational news summary based solely on data contained in Calumet, Inc.'s SEC filing dated November 6, 2026, and publicly available market data. It does not constitute investment advice, a recommendation to buy or sell any security, or a research rating of any kind. Investors should conduct their own due diligence and consult a qualified financial professional before making any investment decisions.

Existing Coverage

StockWatch has full coverage on CLMT, published 2026-09-23. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-11-06. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/2013745/000201374526000032/clmt-20261106.htm